{"id":"W4402131379","doi":"10.1002/cac2.12604","title":"Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Engineering Link (Canada)","funders":"Wu Jieping Medical Foundation; National Natural Science Foundation of China","keywords":"Medicine; Interim analysis; Internal medicine; Clinical endpoint; Hazard ratio; Oncology; Chemotherapy; Neoadjuvant therapy; Perioperative; Esophageal cancer; Adverse effect; Randomized controlled trial; Cancer; Surgery; Confidence interval; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001450482,0.0002625999,0.002026272,0.000537236,0.0001282427,0.00007614869,0.0005706431,0.0001287326,0.0009315691],"category_scores_gemma":[0.0002164829,0.0001911491,0.0007337198,0.001242839,0.0005705518,0.0002154138,0.0001657607,0.0006228066,0.000004324565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001044845,"about_ca_system_score_gemma":0.001729591,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0136622,"about_ca_topic_score_gemma":0.01163416,"domain_scores_codex":[0.9966837,0.0008780733,0.001221819,0.0004966604,0.0003648122,0.0003549622],"domain_scores_gemma":[0.9966915,0.000906485,0.0001909204,0.001682272,0.000264574,0.0002642674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8288866,0.006155162,0.007287693,0.0001904086,0.02003483,0.0001206873,0.01504886,0.0001186537,0.00095527,0.002503153,0.0002705379,0.1184281],"study_design_scores_gemma":[0.9056875,0.002442019,0.00168128,0.0002798162,0.003643741,0.000001773352,0.0005761709,0.08266385,0.001117007,0.0000641372,0.001598043,0.0002446672],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8609058,0.1186877,0.0004475824,0.01101179,0.0008008736,0.005706212,0.0009739501,0.0001350648,0.001331005],"genre_scores_gemma":[0.9712703,0.02156721,0.0006356499,0.0002778032,0.0001733817,0.003753733,0.0002769007,0.00003573415,0.002009308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1181835,"threshold_uncertainty_score":0.9999817,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1068187948094256,"score_gpt":0.512525384030229,"score_spread":0.4057065892208033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}